trending Market Intelligence /marketintelligence/en/news-insights/trending/g5s8wvxne4eczq8o6i5baa2 content esgSubNav
In This List

Evitrade to buy medical technology service company

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Evitrade to buy medical technology service company

Evitrade Health Systems Corp. is acquiring Cantech Molecular Research Inc.

Cantech Molecular Research manufactures plants grown through selective breeding and produces pharmaceutical products for agricultural and medicinal use.

Haywood Securities is acting as financial adviser to Evitrade.

Richmond, British Columbia-based Evitrade is a health technology company that provides biomedical online services for common health issues.